A detailed history of Morgan Stanley transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Morgan Stanley holds 13,555,893 shares of TEVA stock, worth $304 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,555,893
Previous 13,139,202 3.17%
Holding current value
$304 Million
Previous $214 Million 14.41%
% of portfolio
0.02%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $6.59 Million - $7.9 Million
416,691 Added 3.17%
13,555,893 $244 Million
Q2 2024

Oct 17, 2024

BUY
$12.78 - $17.4 $98.6 Million - $134 Million
7,713,582 Added 142.17%
13,139,202 $214 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $98.6 Million - $134 Million
7,713,582 Added 142.17%
13,139,202 $214 Million
Q1 2024

Oct 17, 2024

SELL
$10.67 - $14.43 $82.3 Million - $111 Million
-7,713,582 Reduced 58.71%
5,425,620 $76.6 Million
Q1 2024

Aug 16, 2024

SELL
$10.67 - $14.43 $29.9 Million - $40.4 Million
-2,799,460 Reduced 34.04%
5,425,620 $76.6 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $29.9 Million - $40.4 Million
-2,799,460 Reduced 34.04%
5,425,620 $76.6 Million
Q4 2023

Aug 16, 2024

SELL
$8.12 - $10.63 $39.9 Million - $52.2 Million
-4,914,122 Reduced 37.4%
8,225,080 $85.9 Million
Q4 2023

Feb 13, 2024

BUY
$8.12 - $10.63 $19.6 Million - $25.7 Million
2,416,602 Added 41.6%
8,225,080 $85.9 Million
Q3 2023

Nov 15, 2023

SELL
$7.48 - $10.7 $8.54 Million - $12.2 Million
-1,141,312 Reduced 16.42%
5,808,478 $59.2 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $15 Million - $19.7 Million
2,080,202 Added 42.72%
6,949,790 $52.3 Million
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $11.9 Million - $16.2 Million
-1,424,405 Reduced 22.63%
4,869,588 $43.1 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $3.7 Million - $4.41 Million
465,489 Added 7.99%
6,293,993 $57.4 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $290,994 - $506,907
-42,419 Reduced 0.72%
5,828,504 $47 Million
Q2 2022

Oct 27, 2022

BUY
$7.38 - $10.4 $14.7 Million - $20.7 Million
1,993,556 Added 51.42%
5,870,923 $44.1 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $14.7 Million - $20.7 Million
1,993,556 Added 51.42%
5,870,923 $44.1 Million
Q1 2022

Oct 27, 2022

SELL
$7.33 - $9.39 $14.6 Million - $18.7 Million
-1,993,556 Reduced 33.96%
3,877,367 $36.4 Million
Q1 2022

May 13, 2022

BUY
$7.33 - $9.39 $2.16 Million - $2.77 Million
295,320 Added 8.24%
3,877,367 $36.4 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $7.34 Million - $9.46 Million
928,791 Added 35.01%
3,582,047 $28.7 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $22.2 Million - $27 Million
2,653,256 New
2,653,256 $25.8 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.